0001602462-19-000001.txt : 20190514 0001602462-19-000001.hdr.sgml : 20190514 20190513174150 ACCESSION NUMBER: 0001602462-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190513 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KinDex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001602462 IRS NUMBER: 270767031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339492 FILM NUMBER: 19819691 BUSINESS ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 447-1455 MAIL ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001602462 KinDex Pharmaceuticals, Inc. 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 617-803-5499 DELAWARE None None Corporation true Jeffrey S Bland c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Executive Officer Brent Eck c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Director Jeffrey J Katke c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Director Paul Schimmel c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Director Dennis Ausiello c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Director Michael Higgins c/o 110 Coolidge Hill Cambridge MA MASSACHUSETTS 02138 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-04-26 false true true true false 0 2000000 900000 1100000 false 6 0 0 0 false KinDex Pharmaceuticals, Inc. /s/ Michael Higgins Michael Higgins Chief Executive Officer 2019-05-13